Patents by Inventor Qiru Fan

Qiru Fan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156735
    Abstract: Among others, the present invention provides beta-hydroxybutyrate (BHB) salt granules, comprising BHB salts and fillers. The present invention also provides methods for producing BHB salt granules, wherein the BHB salt granules are prepared by granulation process. The production methods may include (a) wet granulation; (b) extrusion; (c) spheronization; and (d) drying.
    Type: Application
    Filed: April 14, 2021
    Publication date: May 16, 2024
    Applicant: NANJING NUTRABUILDING BIO-TECH CO., LTD.
    Inventors: Long Jiang, Xuyang Sun, Qiru Fan, Ronghua Yi, Kylin Liao
  • Publication number: 20240138449
    Abstract: The present invention provides novel methods for preparing a moisture-proof amino acid material. The present invention also provides novel compositions or nutritional supplements comprising the moisture-proof amino acid materials prepared by the methods of this invention.
    Type: Application
    Filed: March 17, 2022
    Publication date: May 2, 2024
    Applicant: NANJING NUTRABUILDING BIO-TECH CO., LTD.
    Inventors: Jun Tang, Wei Wang, Ou Wang, Qiru Fan, Kylin Liao
  • Publication number: 20240122900
    Abstract: The present invention provides methods, compositions (e.g., eyedrop or spongarion composition), and uses for alleviating and preventing age-associated vitreous degeneration in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, polymer, analog or derivative thereof, as an active ingredient. In particular, L-ergothioneine is capable of scavenging chronic reactive oxygen species directly and radically to mitigate and prevent HA depolymerization and HA decreasing-viscosity in the mammal's vitreous body; and/or improving vitreous liquefaction in the mammal.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Inventors: Ronghua YI, Qiru FAN, Mingru WANG, Ou WANG, Kylin LIAO
  • Publication number: 20230404952
    Abstract: Among others, the present invention provides a liposome comprising an active ingredient and one membrane or one inner membrane and one outer membrane. Each membrane comprises a plurality of lipid molecules, and the active ingredient is entrapped inside the interior space defined by the membrane or the inner membrane, or embodied in the membrane or membranes and form a part of the membrane(s).
    Type: Application
    Filed: August 1, 2023
    Publication date: December 21, 2023
    Inventors: Long JIANG, Xuyang SUN, Qiru FAN, Ronghua YI, Mingru WANG, Kylin LIAO
  • Publication number: 20230218590
    Abstract: Provided are methods for improving exercise performance and endurance of a mammal, comprising administering to the mammal in need thereof a composition comprising dihydroberberine (DHB), or an analog or derivative thereof, and a physiologically acceptable carrier. DHB in the composition can serve as an antioxidant to defend red blood cells against oxidative stress damage, by scavenging reactive oxygen species generated during to increase the deformability and the survival of red blood cells.
    Type: Application
    Filed: October 21, 2021
    Publication date: July 13, 2023
    Applicant: NANJING NUTRABUILDING BIO-TECH CO., LTD.
    Inventors: Qiru Fan, Kylin Liao, Mingru Wang
  • Patent number: 11534426
    Abstract: Among others, the present invention provides novel methods for extending lifespan or improving healthspan in a mammal, which include administration to the mammal of a composition containing a therapeutically effective amount of ergothioneine, or a pharmaceutically acceptable salt, acid, ester, analog or derivative thereof.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: December 27, 2022
    Assignee: Nanjing Nutrabuilding Bio-tech Co., Ltd.
    Inventors: Joseph L. Evans, Qiru Fan, Shawn Wells, Kylin Liao
  • Patent number: 11491141
    Abstract: Glutathione deficiencies and deficiencies in glutathione synthetase activity, and therapeutic methods for the treatment thereof.
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: November 8, 2022
    Assignee: NANJING NUTRABUILDING BIO-TECH CO., LTD.
    Inventors: Joseph L. Evans, Qiru Fan, Shawn Wells, Kylin Liao